WEST PHARMACEUTICAL SERVICES INC — Director's Dealing 2014

Aug 12, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: WEST PHARMACEUTICAL SERVICES INC (WST)
CIK: 0000105770
Period of Report: 2014-08-11

Reporting Person: Lennartz Heino (President Europe)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-08-11	Common Stock	M	7458.0000	$21.3400	Acquired	31431.5370	Direct
2014-08-11	Common Stock	M	3987.0000	$20.4250	Acquired	35418.5370	Direct
2014-08-11	Common Stock	S	11445.0000	$40.0000	Disposed	23973.5370	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2014-08-11	Stock Option (Right to Buy)	$20.4250	M	3987.0000	Disposed	2021-02-21	Common Stock (3987.0000)	Direct
2014-08-11	Stock Option (Right to Buy)	$21.3400	M	7458.0000	Disposed	2020-03-22	Common Stock (7458.0000)	Direct

Footnotes

F1: Reflects additional shares purchased through dividend reinvestments based on most recent plan statement.